HUTCHMED (China) (HCM) Shares Outstanding (2014 - 2025)
HUTCHMED (China)'s (HCM) quarterly Shares Outstanding (Entity) came in at $22.1 million in Q4 2025, little changed year-on-year from $22.0 million in Q4 2024, and down 87.12% on a QoQ basis from $171.4 million in Q2 2025.
HUTCHMED (China) (HCM) Shares Outstanding (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Shares Outstanding (Entity) data on file, last reported at $22.1 million in Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) changed 0.3% year-over-year to $22.1 million in Q4 2025; TTM through Dec 2025 was $22.1 million, a 0.3% change from a year earlier, with the FY2025 full-year figure at $22.1 million, up 0.67% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $22.1 million, down from $171.4 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for HCM reached as high as $171.4 million in Q2 2025 and fell as low as $20.4 million in Q4 2021.
- Historically, Shares Outstanding (Entity) has averaged $74.4 million across 5 years, with a median of $22.0 million in 2025.
- Across the five-year window, Shares Outstanding (Entity) rose 6.42% in 2022 and increased 0.12% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $20.4 million in 2021, then rose by 6.42% to $21.7 million in 2022, then increased by 0.41% to $21.7 million in 2023, then rose by 1.18% to $22.0 million in 2024, then grew by 0.3% to $22.1 million in 2025.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $22.1 million in Q4 2025, $171.4 million in Q2 2025, and $22.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 858.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 858.28 Mn |
| Jun 30, 2025 | 857.04 Mn |
| Dec 31, 2024 | 855.35 Mn |
| Jun 30, 2024 | 856.03 Mn |
| Dec 31, 2023 | 849.65 Mn |
| Jun 30, 2023 | 846.93 Mn |
| Dec 31, 2022 | 847.14 Mn |
| Jun 30, 2022 | 849.28 Mn |
| Dec 31, 2021 | 792.68 Mn |
| Jun 30, 2021 | 729.24 Mn |
| Mar 31, 2021 | 723.18 Mn |
| Dec 31, 2020 | 697.93 Mn |
| Jun 30, 2020 | 685.29 Mn |
| Mar 31, 2020 | 683.86 Mn |
| Dec 31, 2019 | 665.68 Mn |
| Sep 30, 2019 | 665.61 Mn |
| Jun 30, 2019 | 665.55 Mn |
| Mar 31, 2019 | 665.47 Mn |
| Dec 31, 2018 | 664.26 Mn |
| Sep 30, 2018 | 664.00 Mn |